07.20.20 — IPO Boutique Brief: Five IPOs, Four Biotechs, Launch Monday Morning (FREE)

A total of five IPOs launched this morning (Monday, 7/20). Four of the five are  to debut this week but will update the calendar when information becomes available.  This brings the total number of IPOs currently scheduled to debut this week up to six.

Need to know which IPOs to indicate for or which deals have the most demand? We have you covered.

Company: Nurix Therapeutics, Inc.
Symbol: NRIX
Description: They are a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders.
Shares: 8.8 million
Price Range: $16.00-$18.00
Market Cap: $557m-$627
Trade Date: Friday, 7/24
Underwriter(s): JP Morgan, Piper Sandler, Stifel
Co-Manager: Needham
Terms Added: 7-20-20

Company: Inozyme Pharma, Inc.
Symbol: INZY
Description: They are a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton.
Shares: 5 million
Price Range: $14.00-$16.00
Market Cap: $284m-$325m
Trade Date: TBD
Underwriter(s): BofA Securities, Cowen, Piper Sandler
Co-Manager: Wedbush PacGrow
Terms Added: 7-20-20

Company: Annexon, Inc.
Symbol: ANNX
Description: They are a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye.
Shares: 10 million
Price Range: $14.00-$16.00
Market Cap: $438m-$500m
Trade Date: Friday, 7/24
Underwriter(s): JP Morgan, BofA Securities, Cowen
Terms Added: 7-20-20

Company: Vertex, Inc.
Symbol: VERX
Description: Vertex delivers comprehensive tax solutions that enable global businesses to transact, comply and grow with confidence.
Shares: 21.15 million
Price Range: $14.00-$16.00
Market Cap: $2.0bn-$2.3bn
Trade Date: Wednesday, 7/29
Underwriter(s): Goldman Sachs, Morgan Stanley, BofA Securities, Citigroup, Jefferies
Co-Manager: JMP Securities, Stifel, William Blair, CastleOak Securities, L.P.
Terms Added: 7-20-20

Company: iTeos Therapeutics, Inc.
Symbol: ITOS
Description: They are a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients.
Shares: 8.9 million
Price Range: $16.00-$18.00
Market Cap: $508m-$572m
Trade Date: Friday, 7/24
Underwriter(s): JP Morgan, SVB Leerink, Piper Sandler
Co-Manager: Wedbush PacGrow
Terms Added: 7-20-20